PAVmed Inc. (PAVMW)
Price:
0.03 USD
( + 0.01 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Abiomed, Inc.
VALUE SCORE:
0
2nd position
PROCEPT BioRobotics Corporation
VALUE SCORE:
9
The best
Viemed Healthcare, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
NEWS
PAVmed Inc (NASDAQ:PAVM) Sees Large Increase in Short Interest
thelincolnianonline.com
2020-04-28 06:16:42PAVmed Inc (NASDAQ:PAVM) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 36.4% from the March 31st total of 1,290,000 shares. Currently, 5.8% of the shares of the company are short sold. Based on an […]
Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT
finance.yahoo.com
2020-04-10 07:19:38Q4 2019 PAVmed Inc Earnings Call
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
finance.yahoo.com
2020-02-19 12:21:54Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex ...
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
finance.yahoo.com
2020-02-12 14:18:32Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NASDAQ: ...
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
finance.yahoo.com
2020-01-14 12:55:40The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter International ...
No data to display
PAVmed Inc (NASDAQ:PAVM) Sees Large Increase in Short Interest
thelincolnianonline.com
2020-04-28 06:16:42PAVmed Inc (NASDAQ:PAVM) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 36.4% from the March 31st total of 1,290,000 shares. Currently, 5.8% of the shares of the company are short sold. Based on an […]
Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT
finance.yahoo.com
2020-04-10 07:19:38Q4 2019 PAVmed Inc Earnings Call
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
finance.yahoo.com
2020-02-19 12:21:54Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex ...
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
finance.yahoo.com
2020-02-12 14:18:32Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NASDAQ: ...
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
finance.yahoo.com
2020-01-14 12:55:40The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter International ...